Law firms South African sell-down: Slaughters leads as GSK exits Aspen Pharmacare Legal Business · 3 October 2016 · 1 min read Corporate and M&A Deal watch Cleary Gottlieb Slaughter and May Slaughter and May, Cleary Gottlieb Steen & Hamilton and Bowman Gilfillan advised GlaxoSmithKline (GSK) on the sale of its remaining 6.2% stake in Aspen Pharmacare, announced last week.This article is for Legal Business subscribers. Please log in or subscribe to read on. Related ContentMore in this categorySlaughters leads for Anthropic on UK share offer in IPOLaw firmsKate Peacock4 Nov 2026Freshfields lands Anthropic IPO role alongside raft of US firmsLaw firmsEliza Winter26 Oct 2026Cleary makes first-ever California partner promotions in smaller roundLaw firmsEliza Winter26 Oct 2026Paul Hastings set to hire seven-partner, 20-lawyer Weil team for German buildoutLaw firmsWill Lewallen16 Nov 2026Clients ten times more likely to follow their partner after a move, new data showsLegal 500 dataWill Lewallen16 Nov 2026Dechert set to hire senior HSF Kramer partner in London corporate pushLaw firmsWill Lewallen13 Nov 2026Dealwatch: Global 100 advisers take centre stage on BlackRock-GIP $12.5bn mega dealLaw firmsAlex Ryan15 Jan 2024Dealwatch: Telegraph auction off as Barclay brothers pay off Lloyds debt with loanLaw firmsAlex Ryan8 Dec 2023Deal Watch: activity powers on as Latham and A&O lead on $19bn energy joint ventureLaw firmsMegan Mayers9 Sep 2022